| Synonyms: | |
| Status: | Approved (1996) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | J05AG01 |
| UNII: | 99DK7FVK1H |
| InChI Key | NQDJXKOVJZTUJA-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C15H14N4O |
| Molecular Weight | 266.3 |
| AlogP | 2.65 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 58.12 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 20.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Human immunodeficiency virus type 1 reverse transcriptase inhibitor | DailyMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C19
|
- | - | - | - | 12 | |
|
Enzyme
Hydrolase
|
4-9590 | 1-100000 | - | 300-36000 | 48-100 | |
|
Enzyme
Protease
Aspartic protease
Aspartic protease AA clan
Aspartic protease A2A subfamily
|
- | 101-57900 | - | - | - | |
|
Enzyme
|
4-9590 | 1-100000 | - | 300-36000 | 48-100 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| HIV Infections | 4 | D015658 | ClinicalTrials |
| Infections | 3 | D007239 | ClinicalTrials |
| Acquired Immunodeficiency Syndrome | 3 | D000163 | ClinicalTrials |
| Tuberculosis | 3 | D014376 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 63613 |
| ChEMBL | CHEMBL57 |
| DrugBank | DB00238 |
| DrugCentral | 1904 |
| EPA CompTox | DTXSID7031797 |
| FDA SRS | 99DK7FVK1H |
| Human Metabolome Database | HMDB0014383 |
| KEGG | C07263 |
| PDB | NVP |
| PharmGKB | PA450616 |
| SureChEMBL | SCHEMBL3318 |
| ZINC | ZINC000000004778 |